TMPRSS2 and COVID-19: At the beginning of the COVID-19 pandemic, it was believed that the SARS-CoV-2 utilizes the plasma membrane fusion as the default pathway but can switch to the endosomal pathway in the absence of the plasma membrane protease TMPRSS2 (Hoffmann et al., 2020).